The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Bergstein Ivan since 2014.
The trader's CIK number is 1554767.
At the time of the last reporting, Bergstein Ivan was the Chief Executive Officer of Stemline Therapeutics Inc. (stock ticker symbol STML).
Also see all insider trading activities at Stemline Therapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | STML | 0 | $0 | 191,739 | $1,313,334 | 0 | $0 |
| 2019 | STML | 0 | $0 | 212,387 | $2,728,213 | 0 | $0 |
| 2018 | STML | 0 | $0 | 72,657 | $1,263,205 | 0 | $0 |
| 2017 | STML | 0 | $0 | 27,033 | $193,094 | 0 | $0 |
| 2016 | STML | 0 | $0 | 8,781 | $44,035 | 0 | $0 |
| 2015 | STML | 0 | $0 | 15,415 | $144,909 | 0 | $0 |
| 2014 | STML | 2,000 | $22,108 | 11,974 | $172,425 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-04-15 | STML | Sale | 53,618 | 4.88 | 261,655 |
| 2020-03-09 | STML | Sale | 20,909 | 5.09 | 106,426 |
| 2020-03-10 | STML | Sale | 36,542 | 4.92 | 179,786 |
| 2020-02-25 | STML | Sale | 24,642 | 6.42 | 158,201 |
| 2019-12-23 | STML | Sale | 5,225 | 10.58 | 55,280 |
| 2019-12-24 | STML | Sale | 29,613 | 10.97 | 324,854 |
| 2019-12-26 | STML | Sale | 18,744 | 10.75 | 201,498 |
| 2019-12-27 | STML | Sale | 2,446 | 10.48 | 25,634 |
| 2019-08-14 | STML | Sale | 35,010 | 14.73 | 515,697 |
| 2019-06-26 | STML | Sale | 16,994 | 14.77 | 251,001 |
| 2019-06-24 | STML | Sale | 10,822 | 15.49 | 167,632 |
| 2019-06-25 | STML | Sale | 28,500 | 15.10 | 430,350 |
| 2019-03-12 | STML | Sale | 2,151 | 11.05 | 23,768 |
| 2019-03-11 | STML | Sale | 55,073 | 11.11 | 611,861 |
| 2019-03-07 | STML | Sale | 6,800 | 11.41 | 77,588 |
| 2019-02-25 | STML | Sale | 22,905 | 12.03 | 275,547 |
| 2019-02-14 | STML | Sale | 34,132 | 10.98 | 374,769 |
| 2018-03-12 | STML | Sale | 37,857 | 17.68 | 669,122 |
| 2018-03-07 | STML | Sale | 6,797 | 16.56 | 112,558 |
| 2018-02-26 | STML | Sale | 10,776 | 17.61 | 189,765 |
| 2018-02-27 | STML | Sale | 13,407 | 17.26 | 231,404 |
| 2018-02-15 | STML | Sale | 3,820 | 15.80 | 60,356 |
| 2017-03-07 | STML | Sale | 5,401 | 8.13 | 43,910 |
| 2017-02-28 | STML | Sale | 10,480 | 7.01 | 73,464 |
| 2017-02-27 | STML | Sale | 7,500 | 6.97 | 52,275 |
| 2017-02-16 | STML | Sale | 3,652 | 6.42 | 23,445 |
| 2016-03-08 | STML | Sale | 5,537 | 5.34 | 29,567 |
| 2016-02-17 | STML | Sale | 3,244 | 4.46 | 14,468 |
| 2015-11-30 | STML | Sale | 12,235 | 8.20 | 100,326 |
| 2015-02-18 | STML | Sale | 3,180 | 14.02 | 44,583 |
| 2014-11-26 | STML | Sale | 11,974 | 14.40 | 172,425 |
| 2014-09-03 | STML | Buy | 2,000 | 11.05 | 22,108 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bergstein Ivan (Chief Executive Officer of Stemline Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.